A 3-year-old child with multi-drug resistant epilepsy responding to pharmacological and nonpharmacological treatments
Despite the development of new antiseizure drugs (ASDs), around one third of epilepsy patients become refractory to treatment or experience adverse events due to ASDs. Therefore, discovery of new ASDs and new therapy options are crucial to improve the quality of life. Herein, we report a 3-year-old child with multi-drug resistant epilepsy caused by perinatal asphyxia whose seizures were reduced by 90% after the introduction of ketogenic diet, vagal nerve stimulation (VNS) AspireSR (SR-seizure response) and oral cannabidiol.
Keywords: child; multi-drug resistant epilepsy; oral cannabidiol; vagal nerve stimulation AspireSR.
Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex.
Epilepsy Behav. 2016 Oct;63:79-88. doi: 10.1016/j.yebeh.2016.07.034. Epub 2016 Aug 31. Epilepsy Behav. 2016. PMID: 27591681
Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy.
Seizure. 2019 Oct;71:140-144. doi: 10.1016/j.seizure.2019.07.006. Epub 2019 Jul 8. Seizure. 2019. PMID: 31326720
Additional seizure reduction by replacement with Vagus Nerve Stimulation Model 106 (AspireSR).
Neurosci Lett. 2020 Jan 18;716:134636. doi: 10.1016/j.neulet.2019.134636. Epub 2019 Nov 18. Neurosci Lett. 2020. PMID: 31751671
Non-Pharmacological and Non-Surgical Treatment of Refractory Childhood Epilepsy.
Indian J Pediatr. 2020 Dec;87(12):1062-1069. doi: 10.1007/s12098-019-03164-3. Epub 2020 Feb 11. Indian J Pediatr. 2020. PMID: 32048226 Review.
Non-pharmacological Interventions for Intractable Epilepsy.
Saudi Pharm J. 2020 Aug;28(8):951-962. doi: 10.1016/j.jsps.2020.06.016. Epub 2020 Jun 29. Saudi Pharm J. 2020. PMID: 32792840 Free PMC article. Review.